🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 08/01/2004 | 45,75 | 45,88 | 45,35 | 45,88 | +0,52% | 1,15% | 8.032.920 |
| 07/01/2004 | 45,76 | 45,77 | 45,34 | 45,64 | +0,13% | 0,94% | 10.255.309 |
| 06/01/2004 | 45,81 | 45,89 | 45,37 | 45,58 | -0,48% | 1,12% | 8.366.079 |
| 05/01/2004 | 45,90 | 45,90 | 45,20 | 45,80 | +2,02% | 1,52% | 12.495.828 |
| 02/01/2004 | 46,64 | 46,64 | 44,52 | 44,90 | +1,84% | 4,54% | 11.674.615 |
| 31/12/2003 | 43,80 | 44,18 | 43,72 | 44,08 | +1,54% | 1,05% | 9.544.031 |
| 30/12/2003 | 43,60 | 43,64 | 43,27 | 43,42 | -0,42% | 0,83% | 6.311.685 |
| 29/12/2003 | 43,42 | 43,63 | 43,19 | 43,60 | +1,31% | 1,01% | 8.324.788 |
| 26/12/2003 | 42,85 | 43,09 | 42,85 | 43,03 | +0,36% | 0,56% | 1.982.921 |
| 24/12/2003 | 42,66 | 43,10 | 42,57 | 42,88 | +0,38% | 1,25% | 3.534.485 |
| 23/12/2003 | 42,35 | 42,72 | 42,13 | 42,72 | +1,27% | 1,40% | 8.109.738 |
| 22/12/2003 | 42,33 | 42,38 | 41,98 | 42,19 | -0,34% | 0,92% | 7.824.158 |
| 19/12/2003 | 42,61 | 42,67 | 42,10 | 42,33 | -0,54% | 1,34% | 9.504.207 |
| 18/12/2003 | 42,22 | 42,64 | 42,18 | 42,56 | +1,13% | 1,11% | 9.753.107 |
| 17/12/2003 | 42,16 | 42,22 | 41,74 | 42,08 | -0,07% | 1,15% | 7.353.082 |
| 16/12/2003 | 41,92 | 42,31 | 41,80 | 42,11 | +0,98% | 1,21% | 8.217.263 |
| 15/12/2003 | 42,20 | 42,84 | 41,56 | 41,70 | +0,11% | 3,05% | 7.878.759 |
| 12/12/2003 | 41,77 | 41,87 | 41,53 | 41,65 | +0,11% | 0,82% | 5.764.524 |
| 11/12/2003 | 41,12 | 41,71 | 41,10 | 41,60 | +1,04% | 1,49% | 8.709.299 |
| 10/12/2003 | 41,56 | 41,56 | 41,08 | 41,17 | -0,94% | 1,17% | 6.859.684 |
| 09/12/2003 | 41,87 | 41,97 | 41,32 | 41,56 | -0,05% | 1,55% | 9.179.432 |
| 08/12/2003 | 41,04 | 42,19 | 41,01 | 41,58 | +1,18% | 2,86% | 8.316.614 |
| 05/12/2003 | 41,53 | 41,56 | 40,94 | 41,10 | -0,51% | 1,49% | 7.028.726 |
| 04/12/2003 | 41,97 | 42,09 | 41,07 | 41,31 | -0,78% | 2,43% | 10.877.087 |
| 03/12/2003 | 41,43 | 41,91 | 41,41 | 41,63 | +2,66% | 1,20% | 19.695.169 |
| 02/12/2003 | 40,60 | 40,77 | 40,33 | 40,55 | +1,00% | 1,08% | 18.915.142 |
| 01/12/2003 | 39,36 | 40,46 | 39,28 | 40,15 | +3,65% | 2,98% | 18.810.971 |
| 28/11/2003 | 39,10 | 39,12 | 38,71 | 38,74 | -1,02% | 1,05% | 9.343.234 |
| 26/11/2003 | 39,60 | 39,60 | 39,01 | 39,14 | -0,97% | 1,49% | 15.124.422 |
| 25/11/2003 | 40,09 | 40,09 | 39,06 | 39,52 | -1,59% | 2,55% | 21.841.263 |